WallStreetZenWallStreetZen

NASDAQ: APVO
Aptevo Therapeutics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

APVO past revenue growth

How has APVO's revenue growth performed historically?
Company
-100%
Industry
145.73%
Market
17.2%
APVO's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
APVO's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
APVO's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

APVO earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$17.4M
Current Profit Margin
0%

APVO Return on Equity

Current Company
-104.8%
Current Industry
-63.5%
Current Market
188%
APVO's Return on Equity (-104.8%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when APVO announces earnings.

APVO Return on Assets

Current Company
-60.1%
Current Industry
2.9%
APVO is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

APVO Return on Capital Employed

Current Company
-98.83%
Current Industry
19.5%
APVO's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

APVO vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
APVO$0.00-$16.84M-$17.41M-100.00%N/A
ALLR$0.00-$11.28M-$20.42M-100.00%N/A
BPTS$0.00-$15.86M-$18.51MN/AN/A
VRAX$79.30kN/A-$6.92M-15.02%N/A
GRI$0.00-$10.95M-$13.04M-100.00%N/A
View Top Biotech Stocks

APVO earnings dates

Next earnings date
May 9, 2024

Aptevo Therapeutics Earnings & Revenue FAQ

What were APVO's earnings last quarter?

On Invalid Date, Aptevo Therapeutics (NASDAQ: APVO) reported Q4 2023 earnings per share (EPS) of -$6.16, up 85.26% year over year. Total Aptevo Therapeutics earnings for the quarter were -$5.90 million. In the same quarter last year, Aptevo Therapeutics's earnings per share (EPS) was -$41.80.

If you're new to stock investing, here's how to buy Aptevo Therapeutics stock.

What was APVO's earnings growth in the past year?

As of Q2 2024, Aptevo Therapeutics's earnings has grown year over year. Aptevo Therapeutics's earnings in the past year totalled -$17.41 million.

What is APVO's earnings date?

Aptevo Therapeutics's earnings date is Invalid Date. Add APVO to your watchlist to be reminded of APVO's next earnings announcement.

What was APVO's revenue last quarter?

On Invalid Date, Aptevo Therapeutics (NASDAQ: APVO) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Aptevo Therapeutics's revenue was $0.00.

What was APVO's revenue growth in the past year?

As of Q2 2024, Aptevo Therapeutics's revenue has grown -100% year over year. This is 245.73 percentage points lower than the US Biotechnology industry revenue growth rate of 145.73%. Aptevo Therapeutics's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.